LAURIE RAY: Open Payments
NPI 1396015293 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 13 payments from 8 companies in 2025. Trend: 2023 $2,010 · 2024 $571 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $401 |
| Lilly USA, LLC | 1 | $123 |
| Celgene Corporation | 2 | $38 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Incyte Corporation | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $17 |
| SERVIER PHARMACEUTICALS LLC | 1 | $15 |
Products named: QULIPTA, MOUNJARO, REBLOZYL, ULTOMIRIS, Rybelsus, NIKTIMVO, TECVAYLI, UBRELVY.
Industry payments across LA — which companies pay providers there.
